Work alongside those who are similarly driven to provide critical medicine for countless patients in need.
Xentria is a patient-centric biotech company focused on novel biologics and biosimilars. Our first program is XT MAB 16, a monoclonal antibody for sarcoidosis. XT MAB 16 has received Orphan Drug Designation. The Vice President, Quality Assurance is responsible for overseeing and directing the development, implementation and maintenance of quality management practices and systems as governed by GCP, GMP and GLP (GxP) regulations, to ensure compliance with internal policies, business objectives, procedures, and external regulations and standards.